Share this PR

Press Contact

Shushmul Maheshwari

CEO

RNCOS E-Services Pvt. Ltd.

G-199 Sector 63

1204224700

Contact Email

Social Media

Embryoscope: Add-on to Improved Imaging of Uterus

PressReleasePing - May 11, 2017 -Embryoscope is a new technology in the field of In-vitro fertilization. It is an advanced incubator, which allows the embryo to be observed minute by minute from the point when in-vitro fertilization takes place, to the moment when it is transferred into the uterus. This brand new technique, based on the conventional incubators used in clinical embryology laboratories, includes an image capture system, which allows an enormous amount of specific and objective information to be obtained for every embryo, which until now could not be recorded. This allows the doctors to find out new information about the embryos in a non-invasive way, as it avoids the need for taking the embryo out of the incubator to assess its development, improving the selection criteria and, as a result, pregnancy rates. This latest technology promises to change the way embryos are grown and selected in a lab. Moreover, Embryoscope being used for IVF claims to increase fertility success rates in India by 17%. Trivector Scientific Pvt. Ltd., a player in the field of Infertility Management since the last two decades, has launched this new technology in the country. The instrument provides a unique opportunity to develop new parameters for future embryo scoring, and improve embryo assessment in IVF. The development can be seen for five days; and after checking pros and cons, best embryo is transferred to the womb. The Embryoscope is a hi-tech platform (equipment) in which six patients’ totaling 72 embryos are grown and monitored un-interrupted, till they are transferred back to mother’s womb. This also enables doctors to take an informed decision to select and transfer only the best developed embryos from many – avoiding multiple pregnancies and improving overall success rate. According to a new research report by RNCOS entitled, “Indian IVF and PGD Market, By Structure (Independent, Chained, Hospital-based), By region (North, South, East, and West) – Forecasts to 2022”, in India, the Embryoscope has recently been installed in cities including Mumbai, Bangalore, Chennai, Ahmedabad and Patna. The existing users are already planning to order second unit, based on their positive early experience with improved pregnancy rates after using Embryoscope. For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM889.htm Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm ABOUT RNCOS RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.

Creative Commons License

This press release is licensed under a Creative Commons Attribution 3.0 Unported License.